Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
The Australian and New Zealand Journal of Psychiatry
|
April 19, 2017
Longitudinal changes in the antecedent and early manifest course of bipolar disorder-A narrative review of prospective studies
Andrea Pfennig, Karolina Leopold, Philipp Ritter, et al.
Der Nervenarzt
|
February 16, 2022
[Practical aspects of ketamine treatment-Safety, combination treatment and comorbidities]
H Findeis, V Ludwig, P Mikolas, et al.
Scientific Reports
|
May 10, 2022
Advanced sleep spindle identification with neural networks
Lars Kaulen, Justus T C Schwabedal, Jules Schneider, et al.
Current Pharmaceutical Design
|
June 20, 2015
Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders
Pierre Alexis Geoffroy, Bruno Etain, Jean-Arthur Micoulaud Franchi, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 30, 2025
Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review
Jess Kerr-Gaffney, Anna Tröger, Alice Caulfield, et al.
International Journal of Bipolar Disorders
|
July 11, 2024
The influence of PER3 VNTR genotypes on the age of onset in a group of bipolar I disorder patients: an exploratory study
Tommaso Barlattani, Bettina Soltmann, Chiara D'Amelio, et al.
Frontiers in Psychiatry
|
April 10, 2026
Algorithm-guided treatment for major depressive disorder versus treatment as usual: a systematic review
Deni Rkman, René Ernst Nielsen, Rasmus W Licht, et al.
Neuroscience and Biobehavioral Reviews
|
April 16, 2025
EEG markers of cognitive performance in bipolar disorder - A systematic review
Anna Tröger, Pietro Carmellini, Dimosthenis Tsapekos, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 30, 2025
A one-compartment model provides benchmark Lithium dose prediction
Oisín N Kavanagh, Elliot Asprey, Katinka A Edelmann, et al.
CNS Drugs
|
July 20, 2021
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study
Vera M Ludwig, Cathrin Sauer, Allan H Young, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
The Australian and New Zealand Journal of Psychiatry
|
April 19, 2017
Longitudinal changes in the antecedent and early manifest course of bipolar disorder-A narrative review of prospective studies
Andrea Pfennig, Karolina Leopold, Philipp Ritter, et al.
Der Nervenarzt
|
February 16, 2022
[Practical aspects of ketamine treatment-Safety, combination treatment and comorbidities]
H Findeis, V Ludwig, P Mikolas, et al.
Scientific Reports
|
May 10, 2022
Advanced sleep spindle identification with neural networks
Lars Kaulen, Justus T C Schwabedal, Jules Schneider, et al.
Current Pharmaceutical Design
|
June 20, 2015
Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders
Pierre Alexis Geoffroy, Bruno Etain, Jean-Arthur Micoulaud Franchi, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 30, 2025
Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review
Jess Kerr-Gaffney, Anna Tröger, Alice Caulfield, et al.
International Journal of Bipolar Disorders
|
July 11, 2024
The influence of PER3 VNTR genotypes on the age of onset in a group of bipolar I disorder patients: an exploratory study
Tommaso Barlattani, Bettina Soltmann, Chiara D'Amelio, et al.
Frontiers in Psychiatry
|
April 10, 2026
Algorithm-guided treatment for major depressive disorder versus treatment as usual: a systematic review
Deni Rkman, René Ernst Nielsen, Rasmus W Licht, et al.
Neuroscience and Biobehavioral Reviews
|
April 16, 2025
EEG markers of cognitive performance in bipolar disorder - A systematic review
Anna Tröger, Pietro Carmellini, Dimosthenis Tsapekos, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 30, 2025
A one-compartment model provides benchmark Lithium dose prediction
Oisín N Kavanagh, Elliot Asprey, Katinka A Edelmann, et al.
CNS Drugs
|
July 20, 2021
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study
Vera M Ludwig, Cathrin Sauer, Allan H Young, et al.
Page
of 9